Therefore, inhibition by opioid agonists of both the hypothalamus’s pulsatile secretion of the gonadotropin-releasing hormone (gonadoliberin; GnRH) causing hypogonadotropic hypogonadism, and the testosterone secretion directly in the testes occur. The gene discussed is GNRH1; the disease is hypogonadotropic hypogonadism.